Clinical TrialsSearch results
Number of results: 455
Other
- Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematologic diseases (C-SHOT 0402 study)
- Febrile neutropenia
- Center for Supporting Hematology-Oncology Trials (C-SHOT)
- 2005-08-29
Other
- Randomized controlled Phase 3 trial of all-trans retinoic acid(ATRA) versus new synthetic retinoid Tamibarotene(Am80) for maintenance therapy in patients with adult acute promyelocytic leukemia: Japan Adult Leukemia Study Group (JALSG) APL204 Study
- acute promyelocytic leukemia
- Japan Adult Leukemia Study Group (JALSG)
- 2005-09-13
Other
- Randomiszd phase III trial of adjuvant chemotherapy with gemcitabine vs. S-1 in patients with resected pancreatic cancer
- Resected pancreatic cancer
- Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC)
- 2007-04-01
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0803/WJOG4307L)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2008-10-10
Other
- Randomiazed controlled trial comparing docetaxel-cisplatin combination with docetaxel alone in elderly patients with advanced non-small-cell lung cancer(JCOG0207)
- non-small-cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-09
Other
- Randmized controlled trial to test set-therapy and individualized-therapy for elderly acute myelocytic leukemia
- acute myelocytic leukemia
- Japan Adult Leukemia Study Group
- 2005-09-20
Completed
- RAIB-TACE for the Patients with Hepatocellular Carcinoma beyond Up-to 7 Criteria
- Hepatocellular Carcinoma
- Hoshiai Sodai
- 2021-01-29
Other
- RAIB-TACE for Hepatocellular Carcinoma refractory or intolerant to Atezolizumab plus Bevacizumab
- Hepatocellular Carcinoma
- Hasegawa Naoyuki
- 2021-05-26
Not yet recruiting
- Questionnaire survey on the use of alcohol disinfectants in neonatal care
- none
- Hitaka Daisuke
- 2024-11-29
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18